AbCellera Biologics Inc (NASDAQ: ABCL) is -31.06% lower on its value in year-to-date trading and has touched a low of $1.89 and a high of $4.34 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ABCL stock was last observed hovering at around $2.03 in the last trading session, with the day’s loss setting it -0.01%.
Currently trading at $2.02, the stock is -11.05% and -12.10% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.31 million and changing -0.49% at the moment leaves the stock -24.83% off its SMA200. ABCL registered -45.41% loss for a year compared to 6-month loss of -30.82%.
The stock witnessed a -16.53% gain in the last 1 month and extending the period to 3 months gives it a -41.11%, and is -1.94% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.01% over the week and 6.08% over the month.
AbCellera Biologics Inc (ABCL) has around 596 employees, a market worth around $602.94M and $23.12M in sales. Profit margin for the company is -726.23%. Distance from 52-week low is 6.84% and -53.45% from its 52-week high. The company has generated returns on investments over the last 12 months (-15.45%).
The EPS is expected to shrink by -12.62% this year.
AbCellera Biologics Inc (ABCL) Top Institutional Holders
The shares outstanding are 298.36M, and float is at 223.95M with Short Float at 10.27%.
The top institutional shareholder in the company is BAKER BROS. ADVISORS LP with over 27.53 million shares valued at $81.48 million. The investor’s holdings represent 9.3556% of the ABCL Shares outstanding. As of 2024-06-30, the second largest holder is BAILLIE GIFFORD & CO with 21.91 million shares valued at $64.86 million to account for 7.4472 of the shares outstanding. The other top investors are VOYA INVESTMENT MANAGEMENT LLC which holds 10.62 million shares representing 3.611% and valued at over $31.45 million, while CAPITAL WORLD INVESTORS holds 1.8078 of the shares totaling 5.32 million with a market value of $15.74 million.
AbCellera Biologics Inc (ABCL) Insider Activity
#####
